Using a rat stroke model, the team around Jia LI from Shanghai Jiaotong University School of Medicine found that when embryonic stemm cells derived from neural progenitor cells where co-transplanted with blood progenitor cells (ESC-VPCs), a more effective treatment of stroke symptoms was possible.
Nikkei Biotech news release, June 19, 2014